Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Positive Advanced Solid Tumors × Albumin-Bound Paclitaxel × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Advanced Solid Tumor 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumors 1 Solid Tumor 1 Locally Advanced or Metastatic Solid Tumors 1 HER2 Positive Advanced Solid Tumors 1 Cervical Adenocarcinoma 1 Advanced or Metastatic Solid Tumors 1

Interventions

fludarabine 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05681650 2023-12-12

HER2 Targeted HypoSti.CAR-T Cells in HER2 Positive Advanced Solid Tumors

Chinese PLA General Hospital

Phase 1/2 Recruiting

Other solid neoplasm

HER2 Positive Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡